Mahmoudpour, SH;
              
      
            
                Veluchamy, A;
              
      
            
                Siddiqui, MK;
              
      
            
                Asselbergs, FW;
              
      
            
                Souverein, PC;
              
      
            
                de Keyser, CE;
              
      
            
                Hofman, A;
              
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
          
      
            
            
            ... Palmer, CNA; + view all
            
          
      
        
        
        
    
  
(2017)
  Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors.
Pharmacogenetics and Genomics
, 27
       (3)
    
     pp. 112-119.
    
         10.1097/FPC.0000000000000264.
  
  
      
    
  
Preview  | 
            
              
Text
 Asselbergs_Meta-analysis of genome-wide.pdf - Accepted Version Download (1MB) | Preview  | 
          
Abstract
Objectives—To identify SNPs associated with switching from an ACE-inhibitor to an angiotensin receptor blocker (ARB). Methods—Two cohorts of patients starting ACE-inhibitors were identified within the Rotterdam Study in the Netherlands and the GoDARTS study in Scotland. Cases were intolerant subjects who switched from an ACE-inhibitor to an ARB, controls were subjects who used ACE-inhibitors continuously for at least 2 years and did not switch. GWAS using an additive model was run in these sets and results were meta-analysed using GWAMA. Results—972 cases out of 5 161 ACE-inhibitor starters were identified. 8 SNPs within 4 genes reached the GWAS significance level (P<5×10-8) in the meta-analysis (RBFOX3, GABRG2, SH2B1 and MBOAT1). The strongest associated SNP was located in an intron of RBFOX3, which contains a RNA binding protein (rs2061538: MAF=0.16, OR=1.52[95%CI: 1.32-1.76], p=6.2x10-9). Conclusions—These results indicate that genetic variation in abovementioned genes may increase the risk of ACE-inhibitors induced adverse reactions.
| Type: | Article | 
|---|---|
| Title: | Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors | 
| Open access status: | An open access version is available from UCL Discovery | 
| DOI: | 10.1097/FPC.0000000000000264 | 
| Publisher version: | http://doi.org/10.1097/FPC.0000000000000264 | 
| Language: | English | 
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. | 
| Keywords: | ACE inhibitors; ACE-inhibitor intolerance; adverse drug reaction; cough; angioedema; Genome Wide Association Study | 
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics  | 
        
| URI: | https://discovery.ucl.ac.uk/id/eprint/1570836 | 
Archive Staff Only
![]()  | 
        View Item | 
                      
